Trials / Conditions / Respiratory Synctial Virus Infections

Respiratory Synctial Virus Infections

4 registered clinical trials studyying Respiratory Synctial Virus Infections — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Evaluation of the Effect of Nirsevimab on Hospitalizations Due to RSV Infection in Infants Under One Year of A NCT06856967	Meyer Children's Hospital IRCCS	—
Recruiting	A Study to Confirm the Effectiveness and Safety of AK0529 in Treating RSV Infections in Hospitalized Infants NCT06775405	Shanghai Ark Biopharmaceutical Co., Ltd.	Phase 3
Completed	Phase 2 Study of the RSV/Flu-01E Vaccine Against Respiratory Syncytial Virus Infection in Older Adults NCT06890429	Research Institute of Influenza, Russia	Phase 2
Completed	A Study to Assess the Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' RSV Inve NCT02491463	GlaxoSmithKline	Phase 1